BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

514 related articles for article (PubMed ID: 28846793)

  • 21. [Precancerous lesions of the buccal epithelium].
    Renaud-Vilmer C; Cavelier-Balloy B
    Ann Dermatol Venereol; 2017 Feb; 144(2):100-108. PubMed ID: 27939087
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral and Maxillofacial Lesions Diagnosed in Older People of a Brazilian Population: A Multicentric Study.
    Silva LP; Leite RB; Sobral APV; Arruda JA; Oliveira LV; Noronha MS; Kato CO; Mesquita RA; Schuch LF; Gomes APN; Vasconcelos ACU; Souza LB
    J Am Geriatr Soc; 2017 Jul; 65(7):1586-1590. PubMed ID: 28295131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potentially malignant epithelial oral lesions: discrepancies between clinical and histological diagnosis.
    Onofre MA; Sposto MR; Navarro CM; Motta ME; Turatti E; Almeida RT
    Oral Dis; 1997 Sep; 3(3):148-52. PubMed ID: 9467356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The diagnostic value of the native fluorescence visualization device for early detection of premalignant/malignant lesions of the oral cavity.
    Amirchaghmaghi M; Mohtasham N; Delavarian Z; Shakeri MT; Hatami M; Mosannen Mozafari P
    Photodiagnosis Photodyn Ther; 2018 Mar; 21():19-27. PubMed ID: 29079347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Epidemiology, aetiology, and clinical aspects of oral cancer and premalignant lesions].
    van der Meij EH
    Ned Tijdschr Tandheelkd; 2008 Apr; 115(4):186-91. PubMed ID: 18512516
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Precancerous lesions of the buccal mucosa].
    Ben Slama L
    Rev Stomatol Chir Maxillofac; 2001 Apr; 102(2):77-108. PubMed ID: 11446145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo Raman spectroscopic identification of premalignant lesions in oral buccal mucosa.
    Singh SP; Deshmukh A; Chaturvedi P; Murali Krishna C
    J Biomed Opt; 2012 Oct; 17(10):105002. PubMed ID: 23223996
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Premalignant and malignant lesions of oral cavity in eastern India: a hospital-based study.
    Sahoo PK; Sarkar S; Ghosh D; Mahata S; Pal R; Mistry T; Ghosh S; Roy A; Bucha H; Mandal S; Nasare VD
    Eur J Cancer Prev; 2021 Sep; 30(5):393-399. PubMed ID: 33252366
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct immunofluorescence testing results in cases of premalignant and malignant oral lesions.
    Montague LJ; Bhattacharyya I; Islam MN; Cohen DM; Fitzpatrick SG
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2015 Jun; 119(6):675-83. PubMed ID: 25840514
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The malignant degeneration of lichen ruber planus of the oral mucosa].
    Gushcha RG; Belikov ES; Brodskaia IK; Startseva LA
    Stomatologiia (Mosk); 1994; 73(1):15-6. PubMed ID: 8191508
    [No Abstract]   [Full Text] [Related]  

  • 31. p53 expression above the basal cell layer in oral mucosa is an early event of malignant transformation and has predictive value for developing oral squamous cell carcinoma.
    Cruz IB; Snijders PJ; Meijer CJ; Braakhuis BJ; Snow GB; Walboomers JM; van der Waal I
    J Pathol; 1998 Apr; 184(4):360-8. PubMed ID: 9664901
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive and Nonreactive White Lesions of the Oral Mucosa.
    Fitzpatrick SG
    Oral Maxillofac Surg Clin North Am; 2023 May; 35(2):237-246. PubMed ID: 37019506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features of premalignant and malignant mucosal disease of the oral cavity.
    Vincent SD
    Compr Ther; 1987 Jun; 13(6):61-6. PubMed ID: 3581750
    [No Abstract]   [Full Text] [Related]  

  • 34. Evaluation of nuclear morphometry and DNA ploidy status for detection of malignant and premalignant oral lesions: quantitative cytologic assessment and review of methods for cytomorphometric measurements.
    Pektas ZO; Keskin A; Günhan O; Karslioğlu Y
    J Oral Maxillofac Surg; 2006 Apr; 64(4):628-35. PubMed ID: 16546642
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oral precancerous conditions--an overview].
    Reichart PA
    Mund Kiefer Gesichtschir; 2003 Jul; 7(4):201-7. PubMed ID: 12961069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management for premalignant lesions of the oral cavity.
    Panwar A; Lindau R; Wieland A
    Expert Rev Anticancer Ther; 2014 Mar; 14(3):349-57. PubMed ID: 24559323
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective study of the progression of oral premalignant lesions to squamous cell carcinoma: a South Wales experience.
    Bromwich M
    J Otolaryngol; 2002 Jun; 31(3):150-6. PubMed ID: 12121018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of oral mucosal abnormalities in addiction treatment centre residents in Southern Ireland.
    O'Sullivan EM
    Oral Oncol; 2011 May; 47(5):395-9. PubMed ID: 21441065
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Toluidine blue aids in detection of dysplasia and carcinoma in suspicious oral lesions.
    Chainani-Wu N; Madden E; Cox D; Sroussi H; Epstein J; Silverman S
    Oral Dis; 2015 Oct; 21(7):879-85. PubMed ID: 26173924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epidemiological study of 534 biopsies of oral mucosal lesions in elderly Brazilian patients.
    Carvalho Mde V; Iglesias DP; do Nascimento GJ; Sobral AP
    Gerodontology; 2011 Jun; 28(2):111-5. PubMed ID: 20518812
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.